Embolic Protection Devices Market Research Report – Forecast to 2027

Embolic Protection Devices Market Information: By type (Distal Filter Devices, Proximal Occlusion Devices), Material (Nitinol), Usage (Disposable Devices), Application (Cardiovascular Diseases), End-User (Hospitals & Clinics) - Global Forecast Till 2023

ID: MRFR/MED/4520-HCR | February 2021 | Region: Global | 100 pages         

Embolic Protection Devices Market

The Embolic Protection Devices Market was valued at USD 984.40 million and is expected to register a CAGR of 8.5% during the forecast period

Segmentation

By Type Distal Filter Devices Distal Occlusion Devices Proximal Occlusion Devices
By Material Nitinol Polyurethane
By Usage Disposable Devices Re-usable Devices
By Application Cardiovascular Diseases Coronary Artery Diseases Trans Cather Aortic Valve Replacement Saphenous Vein Graft Disease Neurovascular Diseases Peripheral Vascular Diseases
By End-User Hospitals & Clinics Ambulatory Surgical Centers Specialty Centers

Key Players

  • Medtronic
  • Abbott
  • Boston Scientific
  • Cordis
  • Contego Medical
  • W. L. Gore & Associates
  • Claret Medical
  • Allium Medical Solutions
  • Angioslide

Drivers

  • High prevalence of cardiovascular diseases
  • Increasing technical advanced devices
  • Increasing demand for minimally invasive procedures
Speak to Analyst Request a Free Sample

Embolic Protection Devices Market Scenario


The embolic protection devices market was valued at USD 400 million in 2017 and is expected to register a CAGR of 8.5% during the forecast period. The embolic protection devices market is majorly driven by the high prevalence of cardiovascular diseases, increasing technical advanced devices, increasing demand for minimally invasive procedures, and growing penetration by market players. Additionally, factors such as the increasing approval for embolic protection devices, government initiatives and support, and increasing reimbursement coverage for cardiologic anomalies are likely to drive the embolic protection devices market.


However, factors such as product failures and recalls are likely to hamper the growth of the embolic protection devices market.


Key Players                                                                                                         


Some of the key players in the Embolic Protection Devices market are Medtronic, Abbott, Boston Scientific, Cordis, Contego Medical, W. L. Gore & Associates, Claret Medical, Allium Medical Solutions, and Angioslide.


Intended Audience



  • Pharmaceutical Manufacturers and Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Market Segmentation                                                                                                                          


The embolic protection devices market is segmented on the basis of type, material, usage, application, and end-user. Considering type, the market is segmented into distal filter devices, distal occlusion devices, and proximal occlusion devices. By material, the market is segmented into nitinol and polyurethane. By usage, the market is segmented into disposable devices and reusable devices. With reference to application, the market is segmented into cardiovascular diseases, neurovascular diseases, and peripheral vascular diseases. Furthermore, on cardiovascular diseases, the market is segmented into coronary artery diseases, trans Cather aortic valve replacement, and saphenous vein graft disease. On account of end-user, the market is segmented into hospitals and clinics, specialty centers, and ambulatory surgical centers. Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas region is segmented into North America and South America. Further, North America is segmented into two major countries, namely, the U.S. and Canada.


Regional Market Summary


The increasing prevalence of cardiovascular diseases and neurovascular disorders are likely to enhance the growth of embolic protection devices. Additionally, factors such as the increasing demand for minimally invasive procedures, increasing government support, and the increasing demand for technologically advanced treatments are likely to enhance the growth of the embolic protection devices market in North America. For instance, according to the American Heart Association, in 2014, around 31% of the deaths in the U.S. were due to cardiovascular disorders. Similarly, according to the Center for Disease Control and Prevention, in 2015, around USD 3.2 trillion were spend in healthcare expenditure in the U.S. This growing rate in cardiovascular disorders is expected to have a direct effect on embolic protection devices as they find application majority in cardiovascular procedures.  Additionally, the increasing healthcare expenditure is likely to propel the growth of the market in the U.S. region.


Europe is the second largest market and holds a healthy share in the global embolic protection devices market. The European market is expected to grow at a strong growth rate during the forecast period owing to the availability of advanced treatment facilities and healthcare expenditure along with the growing need for better healthcare infrastructure. Furthermore, the increasing cardiovascular rate, along with the population inclined towards the sedentary lifestyle is driving the growth of the embolic protection devices market. According to the European Heart Network, in 2015, there were 11.3 million cardiovascular disorder cases in Europe. These increasing occurrences of cardiovascular disorders are expected to have a positive impact on the embolic protection devices market due to their wide usage in cardiac-related disorders. These impacts are likely to enhance the embolic protection devices market in Europe.


Asia Pacific is expected to be the fastest growing market. Factors such as the increasing prevalence of chronic diseases are the major drivers for the market growth. China is expected to be the fastest growing country due to increasing population and raising awareness about the health and availability of new treatment methods. Moreover, the increasing healthcare expenditure and improvement in the standard of living are driving the growth of the embolic protection devices market in the Asia Pacific region. For instance, the New South Wales (NSW) Government is expected to fund over USD 8 million for the development of medical devices during 2018 to 2019. This funding will help to encourage and support investments in the development and commercialization of medical devices and related technologies in New South Wales (NSW). This investment for the development of medical devices is also likely to push the growth of the embolic protection devices market in the Asia Pacific region.


The Middle East and Africa is expected to show the least growth in the market due to some major factors such as lack of awareness and limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates is the largest market owing to the development of the healthcare industry and the increasing availability of specialty care centers.


Global Embolic Protection Devices Market Share (%), by Region, 2017


 Embolic Protection Devices Market


Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, annual report, white paper, company presentation and market research future analysis


Market Segmentation 


Embolic Protection Device Market, by Type



  • Distal Filter Devices

  • Distal Occlusion Devices

  • Proximal Occlusion Devices

  • Embolic Protection Device Market, by Material

  • Nitinol

  • Polyurethane

  • Embolic Protection Device Market, by Usage

  • Disposable devices

  • Re-usable devices

  • Embolic Protection Device Market, by Application

  • Cardiovascular Diseases

  • Coronary Artery Diseases

  • Trans Cather Aortic Valve Replacement

  • Saphenous Vein Graft Disease

  • Neurovascular Diseases

  • Peripheral Vascular Diseases


 Embolic Protection Device Market, by End-User



  • Hospitals & Clinics

  • Ambulatory Surgical Centers

  • Specialty Centers


Embolic Protection Devices Market, by Region



  • Americas


    • North America


      • US

      • Canada


    • Latin America


  • Europe


    • Western Europe


      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe


    • Eastern Europe


  • Asia-Pacific


    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific


  • The Middle East & Africa


    • Middle East

    • Africa



Research Methodology:


 Embolic Protection Devices Methodology


Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, annual report, white paper, company presentation and market research future analysis



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2017: USD 400 Million
  • 2027: Significant Value
  •   CAGR   8.5% (2017-2023)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2017
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Type, Material, Usage, Application, and End-user
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Medtronic, Abbott, Boston Scientific, Cordis, Contego Medical, W. L. Gore & Associates, Claret Medical, Allium Medical Solutions, and Angioslide.
      Key Market Opportunities

  • Increasing approval for embolic protection devices
  • Government initiatives and support
  • Increasing reimbursement coverage for cardiologic anomalies
  •   Key Market Drivers

  • High prevalence of cardiovascular diseases
  • Increasing technical advanced devices
  • Increasing demand for minimally invasive procedures
  • Growing penetration by market players


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The embolic protection devices market would register a CAGR of 8.5% during the forecast period covering 2018 to 2023.

    The embolic protection devices market growth can be halted by product failures and recalls.

    Players with a prominent impact on the embolic protection devices market are Abbott, Medtronic, Contego Medical, W. L. Gore & Associates, Boston Scientific, Cordis, Allium Medical Solutions, Claret Medical, and Angioslide.

    The Asia Pacific region has the chance to record the highest growth rate for the embolic protection devices market.

    The North American embolic protection devices market would earn more than others in terms of revenue.